Inventor
OKUMURA YOSHIYUKI
JP18 patents
⚠️ This page may combine multiple inventors who share the name “OKUMURA YOSHIYUKI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
10 patentsUS5883106AMar 16, 1999
5-lipoxygenase inhibitors
PFIZER58 citations96
US6310079B1Oct 30, 2001
Benzimidazole cyclooxygenase-2 inhibitors
PFIZER26 citations92
US7141580B2Nov 28, 2006
Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
PFIZER19 citations90
US6710054B2Mar 23, 2004
Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
PFIZER35 citations90
US6063928AMay 16, 2000
5-lipoxygenase inhibitors
PFIZER7 citations73
US6291520B1Sep 18, 2001
Hydroxamic acid and N-hydroxyurea derivatives and their use
PFIZER6 citations62
US5681858AOct 28, 1997
Cycloalkyl hydroxyureas
PFIZER6 citations62
US5521212AMay 28, 1996
Cyclopropyl N-hydroxyurea and N-hydroxyacetamides which inhibit lipoxygenase
PFIZER3 citations62
US6444677B2Sep 3, 2002
5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists
PFIZER6 citations59
US6713482B2Mar 30, 2004
Benzimidazole cyclooxygenase-2 inhibitors
PFIZER0 citations52
ASKAT INC
3 patentsUS9447066B2Sep 20, 2016
Salts and crystal forms
ASKAT INC8 citations82
US11964963B2Apr 23, 2024
Stable salt and crystal forms of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2-dimethylpropyl)-1H-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol
ASKAT INC0 citations55
US11555023B2Jan 17, 2023
Process for the differential solubility-driven asymmetric transformation of substituted 2H-chromene-3-carboxylic acids
ASKAT INC0 citations36